摘要
目的：研究分析应用左卡尼汀与芪苈强心胶囊治疗缺血性心肌病的临床效果。方法随机将2013年1月～2014年7月我院缺血性心肌病患者156例分成对照组和治疗组各78例，对照组应用常规方法治疗，治疗组同时应用左卡尼汀与芪苈强心胶囊联合治疗，对两组的临床效果以及心功能指标的变化进行比较。结果对照组总有效率为71.8%、治疗组总有效率为92.3%、两组比较差异具有统计学意义（P＜0.05）；治疗组左室射血分数（LVEF）、心排出量（CO）、每搏量（SV）、左室短径缩短率（LVFS）各项指标均优于对照组，两组比较差异具有统计学意义（P＜0.05）。结论应用左卡尼汀与芪苈强心胶囊联合治疗缺血性心肌病具有显著地增强心肌收缩力、提高心功能的功效、短期临床效果确切，治疗安全可靠，应用前景广泛。
Objective To research and explore the clinical effect of combinedLevocarnitine and Qiliqiangxin capsulefor treatment of ischemic cardiomyopathy. Methods Randomly divided 156 cases patients to treatment group and control group,each group has 78 cases.The control group applied Conventional treatment,at the same time the treatment group applied injection of levocarnitine andQiliqiangxin capsule. To compare the clinical effect and the changes of Cardiac function indexes（LVEF,CO,SV,LVFS）. Results The total effective rate incontrol groupwas71.8%, The total effective rate intreatment group was 92.3%, the difference was significant（P〈0.05）; The change of LVEF,CO,SV,LVFS in treatment group were better than control group,the difference was significant（P〈0.05）. Conclusion The application of levocamitine and Qiliqiangxin capsulefor treatmentof ischemic cardiomyopathy has the efficacy of increasing myocardial contraction force and improving cardiac functionsignificantly.The short-term clinical effect was exact,the treatment was safe and reliable,and could be widely applicated.
出处
《中国卫生标准管理》
2015年第1期62-63,共2页
China Health Standard Management
